Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer
/in Colorectal Cancer, Gastric Cancer, International Publications, MicronutrientsDendritic cell vaccine with Ag85A enhances anti-colorectal carcinoma immunity
/in Colorectal Cancer, Dendritic Cells, International PublicationsA randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis
/in Colorectal Cancer, Dendritic Cells, International PublicationsVitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour
/in Colorectal Cancer, International Publications, MicronutrientsCombined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients
/in Colorectal Cancer, Dendritic Cells, International PublicationsHyperthermia enhances radiosensitivity of colorectal cancer cells through ROS inducing autophagic cell death
/in Colorectal Cancer, Hyperthermia, International PublicationsModulated electro-hyperthermia induced loco-regional and systemic tumor destruction in colorectal cancer allografts
/in Colorectal Cancer, Hyperthermia, International PublicationsEvaluation of the oncolytic potential of RB Mukteshwar vaccine strain of Newcastle disease virus (NDV) in a colon cancer cell line (SW-620)
/in Colorectal Cancer, International Publications, Newcastle Disease VirusCombination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model
/in Colorectal Cancer, Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer